Cleantech & EV'sNews

Toyota, Japanese rivals promise more efficient next-gen ICE engines amid the shift to EVs

May 29, 2024
Despite the market moving toward EVs, Toyota, Subaru, and Mazda are committed to developing next-generation ICE engines. The new engines are “tailored to electrification” with integrated EV components. Toyota, Subaru, Mazda, double down on ICE engines Japanese automakers have been some of the biggest laggards in the transition to fully electric. As a result, Toyota was once again the…
Read more
CryptoNews

Ethereum Futures Open Interest Hits All-Time High Following ETF Approvals

May 29, 2024
Ethereum has experienced a significant increase since the U.S. Securities and Exchange Commission (SEC) approved a group of spot ether exchange-traded funds (ETFs). This week, ether reached a high of $3,980 per coin, which is approximately 18.4% below its all-time high. Amid fluctuating prices, ethereum futures markets have achieved a record high in open interest. Ether Futures Markets Reach…
Read more
CryptoNews

US Jury Convicts Two in $8M Crypto-Linked Dark Web Drug Scheme

May 29, 2024
A federal jury in Salt Lake City convicted Oluwole Adegboruwa and Enrique Isong, foreign nationals, of multiple drug-related charges. From 2016 to 2019, they generated over $8 million in cryptocurrency, including bitcoin and ethereum. Adegboruwa operated under the names…
CryptoNews

Hedge Funds Adopt Net Short Positions on BTC and ETH Futures, Kaiko Analysis Reveals

May 27, 2024
In a recent analysis by Kaiko, it has been found that hedge funds are currently holding net short positions on bitcoin (BTC) and ether (ETH) futures. This strategic move reflects a cautious stance amid fluctuating market dynamics and speculative trading activities. Study Shows Hedge Funds’ Net Short Positions in Bitcoin and Ether Futures Amid Market Volatility The report suggests that the net…
Read more
AI & RoboticsNews

McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI

May 24, 2024
Atropos Health, a healthcare technology company focused on generating personalized real-world evidence, announced today that it has raised $33 million in a Series B funding round. The round included strategic investments from healthcare giants McKesson, Merck, and Cencora Ventures, signaling strong industry interest in Atropos’ mission to bring automated, high-quality evidence to patient care…
Read more